Newsletter | May 6, 2026

05.06.26 -- Why Major Retail Pharmacy Chains Struggled To Make The Model Work At Scale

SPONSOR

Accessing Patients Is the Bottleneck: How to Improve Patient ID and Retention in Chronic Disease Trials

Patient enrollment remains a major risk to chronic disease trial timelines, driven by limited capacity and access. More studies compete for the same patients, and research sites are increasingly saturated. Meanwhile, most chronic disease care occurs in primary care settings. Explore how engaging primary care physicians can expand access and elevate clinical research efforts. Click here to learn more.

DECENTRALIZED TRIALS

The Rise — And Stall — Of Retail Pharmacy Clinical Trials

From The Editor | By Dan Schell, chief editor, Clinical Leader

As rumors swirl that Walgreens may be reassessing its clinical trials business, this article explores a broader trend: why major retail pharmacy chains like CVS, Walmart, and Kroger have struggled to make the model work at scale.

Post-Marketing Studies And Real-World Evidence Clinical Trials

Product | 20/20 Onsite

Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.

SPONSOR

Integrating Clinical Operations and Pharmacovigilance for Safer Trials

Break down silos and strengthen trial outcomes. Join Ergomed experts to explore how integrating clinical operations, medical monitoring, and pharmacovigilance from the start improves oversight, reduces delays, and enhances safety decisions. Gain practical strategies to streamline complex studies, minimize risk, and keep development timelines on track with a more connected, efficient, scalable, and proactive, and future-ready, data-driven approach. Click here to learn more.

TRIAL MANAGEMENT

Don't Let The Nocebo Effect In Psychedelic Trials Become A Regulatory Problem

Guest Column | By Jama Pittman, Rose Hill Life Sciences

When a patient feels no effect or a worsening effect because a known treatment effect was or wasn't experience, that's the "nocebo" effect. Strategic Advisor Jama Pittman discusses how this effect could impact regulatory reviews.

Reduction Of Screen Failures In A Biomarker

Article | Flourish Research

Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.

 

Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

Article | By Kurt Preugschat, Precision for Medicine

The benefits are clear: CRM accelerates dose finding, reduces patient exposure to unsafe doses, and improves trial efficiency.

Global Vaccine Clinical Trials: Australia's Strategic Advantage

White Paper | Southern Star Research

The global vaccine clinical trials landscape presents unprecedented opportunities. This report analyses emerging trends, regional opportunities, and Australia’s distinctive strengths in vaccine development.

A High-Touch, Patient-Centered Approach To Rare Disease Trials

Article | By Alex Kavros, John Mann, and Kevin Leach, Avance Clinical

On your journey to developing and executing a successful rare disease trial, it is critical to focus on patient experience and accessibility from the earliest stages of trial design.

The Shift Toward Self-Administration And Integrated Supply Chains

Video | Thermo Fisher Scientific

Adopt integrated, end-to-end clinical supply strategies that enable self-administered therapies, reduce patient burden, and accelerate clinical trial timelines while improving access and outcomes.

The Analytics Platform For Vendor Selection And Management

Product | ClinAI

Find help centralizing RFPs, budgets, and vendor data—so you can select the right partners, manage change orders, and keep your studies on track.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: